Should we use beta-blockers to slow the progression of gliomas as in other neoplasms (e.g., breast, ovary, and prostate)?
DOI:
https://doi.org/10.52329/AvanMed.45Keywords:
adrenergic beta-agonists, glioma, disease progression, breast neoplasms, ovary, prostateDownloads
Download data is not yet available.
Downloads
Published
2022-01-31
How to Cite
1.
Plauto LL de C, Resende RM de. Should we use beta-blockers to slow the progression of gliomas as in other neoplasms (e.g., breast, ovary, and prostate)?. am [Internet]. 2022 Jan. 31 [cited 2024 Dec. 22];1(4):168-70. Available from: https://jornalavancosmedicina.com/index.php/am/article/view/60
Issue
Section
COMENTÁRIO
License
Copyright (c) 2022 Luana Lira de Carvalho Plauto, Rafaela Magalhães de Resende
This work is licensed under a Creative Commons Attribution 4.0 International License.